Corindus Vascular Robotics, Inc. (AMEX: CVRS) was established on May 4, 2011. Its predecessor was Your Internet Defender Inc. (“YIDI”). After several reorganizations and acquisitions, it was changed to August 12, 2014. Current name, headquartered in Waltham, Massachusetts, USA, with 68 full-time employees (5/11/2015), is a medical device company engaged in vascular surgery.
Corindus Vascular Robotics:
The company designs, manufactures and sells precision vascular robotic assist systems (“CorPath® system” for short) used in vascular surgery. Corindus Vascular Robotics’s first and current product is the “CorPath 200 system”, which is an American food and The only percutaneous coronary intervention (“PCI”) procedure approved by the Drug Administration (“FDA”) to help improve precision and accuracy when placing stents.
Although Corindus Vascular Robotics initially aimed at PCI procedures, its leading technology platform enables it to develop peripheral applications. It has a promising future in the vascular market surgery market, including peripheral vascular disease surgery, neurointervention, and cardiac intervention.
Corindus Vascular Robotics investment:
As of December 31, 2014, Corindus Vascular Robotics has installed 24 sets of precision vascular robotic assistance systems (“CorPath® System”) in hospitals in the United States, and successfully installed 2 sets abroad.
Given that human life is getting better and better, cardiovascular disease has become a trend and frequently-occurring disease, and heart and blood vessel bypass surgery will become more and more common, which will boost the company’s performance. The company is different from the general clinical stage company , it has formed sales channels and leading products, it is recommended to pay attention!
The company submitted a prospectus to the SEC on May 11, 2015, and landed on NYSE MKT on May 29, 2015. It plans to raise US$40 million, stock code: CVRS.